Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.

Braess J, Amler S, Kreuzer KA, Spiekermann K, Lindemann HW, Lengfelder E, Graeven U, Staib P, Ludwig WD, Biersack H, Ko YD, Uppenkamp MJ, De Wit M, Korsten S, Peceny R, Gaska T, Schiel X, Behringer DM, Kiehl MG, Zinngrebe B, Meckenstock G, Roemer E, Medgenberg D, Spaeth-Schwalbe E, Massenkeil G, Hindahl H, Schwerdtfeger R, Trenn G, Sauerland C, Koch R, Lablans M, Faldum A, Görlich D, Bohlander SK, Schneider S, Dufour A, Buske C, Fiegl M, Subklewe M, Braess B, Unterhalt M, Baumgartner A, Wörmann B, Beelen D, Hiddemann W; AML-CG.

Leukemia. 2018 Dec;32(12):2558-2571. doi: 10.1038/s41375-018-0268-9. Epub 2018 Oct 1.

2.

Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.

Mack EKM, Marquardt A, Langer D, Ross P, Ultsch A, Kiehl MG, Mack HID, Haferlach T, Neubauer A, Brendel C.

Haematologica. 2019 Feb;104(2):277-287. doi: 10.3324/haematol.2018.194258. Epub 2018 Sep 6.

3.

Consensus statement for cancer patients requiring intensive care support.

Kiehl MG, Beutel G, Böll B, Buchheidt D, Forkert R, Fuhrmann V, Knöbl P, Kochanek M, Kroschinsky F, La Rosée P, Liebregts T, Lück C, Olgemoeller U, Schalk E, Shimabukuro-Vornhagen A, Sperr WR, Staudinger T, von Bergwelt Baildon M, Wohlfarth P, Zeremski V, Schellongowski P; Consensus of the German Society of Hematology and Medical Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN).

Ann Hematol. 2018 Jul;97(7):1271-1282. doi: 10.1007/s00277-018-3312-y. Epub 2018 Apr 27.

4.

Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group.

Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, von Tresckow J, Maurer C, Bergmann M, Seiler T, Lange E, Kneba M, Stilgenbauer S, Döhner H, Kiehl MG, Jäger U, Wendtner CM, Fischer K, Goede V, Hallek M, Eichhorst B, Hopfinger G.

Leukemia. 2017 Oct;31(10):2251-2253. doi: 10.1038/leu.2017.221. Epub 2017 Jul 12. No abstract available.

PMID:
28745332
5.

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.

Boch T, Spiess B, Cornely OA, Vehreschild JJ, Rath PM, Steinmann J, Heinz WJ, Hahn J, Krause SW, Kiehl MG, Egerer G, Liebregts T, Koldehoff M, Klein M, Nolte F, Mueller MC, Merker N, Will S, Mossner M, Popp H, Hofmann WK, Reinwald M, Buchheidt D.

Clin Microbiol Infect. 2016 Oct;22(10):862-868. doi: 10.1016/j.cmi.2016.06.021. Epub 2016 Jul 5.

6.

Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.

Kiehl MG, Egerer G, Engelhardt M, Gross B.

Mycoses. 2015 Feb;58(2):76-81. doi: 10.1111/myc.12277. Epub 2015 Jan 15.

PMID:
25590660
7.

[Tumor-induced hypercalcemia].

Hopfer O, Gawliczek A, Kiehl MG.

Internist (Berl). 2013 Sep;54(9):1043-50. doi: 10.1007/s00108-013-3262-3. German.

PMID:
23934479
8.

Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis.

Reinwald M, Buchheidt D, Hummel M, Duerken M, Bertz H, Schwerdtfeger R, Reuter S, Kiehl MG, Barreto-Miranda M, Hofmann WK, Spiess B.

PLoS One. 2013;8(2):e56706. doi: 10.1371/journal.pone.0056706. Epub 2013 Feb 22.

9.

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Bornhäuser M, Kienast J, Trenschel R, Burchert A, Hegenbart U, Stadler M, Baurmann H, Schäfer-Eckart K, Holler E, Kröger N, Schmid C, Einsele H, Kiehl MG, Hiddemann W, Schwerdtfeger R, Buchholz S, Dreger P, Neubauer A, Berdel WE, Ehninger G, Beelen DW, Schetelig J, Stelljes M.

Lancet Oncol. 2012 Oct;13(10):1035-44. doi: 10.1016/S1470-2045(12)70349-2. Epub 2012 Sep 7.

PMID:
22959335
10.

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.

Reinwald M, Hummel M, Kovalevskaya E, Spiess B, Heinz WJ, Vehreschild JJ, Schultheis B, Krause SW, Claus B, Suedhoff T, Schwerdtfeger R, Reuter S, Kiehl MG, Hofmann WK, Buchheidt D.

J Antimicrob Chemother. 2012 Sep;67(9):2260-7. doi: 10.1093/jac/dks208. Epub 2012 Jun 27.

PMID:
22740590
11.

Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.

Bornhäuser M, Oelschlaegel U, Platzbecker U, Bug G, Lutterbeck K, Kiehl MG, Schetelig J, Kiani A, Illmer T, Schaich M, Theuser C, Mohr B, Brendel C, Fauser AA, Klein S, Martin H, Ehninger G, Thiede C.

Haematologica. 2009 Nov;94(11):1613-7. doi: 10.3324/haematol.2009.007765.

12.

Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.

Vehreschild JJ, Böhme A, Reichert D, Kiehl MG, Arenz D, Pankraz K, Kochanek M, Ullmann AJ, Cornely OA.

Int J Hematol. 2008 Mar;87(2):126-131. doi: 10.1007/s12185-008-0045-z. Epub 2008 Feb 21.

13.
14.

Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors.

Blau IW, Schmidt-Hieber M, Basara N, Hopfenmüller W, Bischoff M, Günzelmann S, Kirsten D, Schmetzer B, Roemer E, Kiehl MG, Thiel E, Fauser AA.

Clin Transplant. 2007 Jan-Feb;21(1):110-6.

PMID:
17302599
15.

Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Penack O, Beinert T, Buchheidt D, Einsele H, Hebart H, Kiehl MG, Massenkeil G, Schiel X, Schleicher J, Staber PB, Wilhelm S, Wolf HH, Ostermann H; German Society of Hematology and Oncology.

Ann Hematol. 2006 Jul;85(7):424-33. Epub 2006 Apr 12. Erratum in: Ann Hematol. 2006 Sep;85(9):639. Wolf, Hans [corrected to Wolf, Hans-Heinrich].

PMID:
16609901
16.

Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.

Bornhäuser M, Kröger N, Schwerdtfeger R, Schafer-Eckart K, Sayer HG, Scheid C, Stelljes M, Kienast J, Mundhenk P, Fruehauf S, Kiehl MG, Wandt H, Theuser C, Ehninger G, Zander AR; Cooperative German Transplant Study Group.

Eur J Haematol. 2006 Jan;76(1):9-17.

PMID:
16343266
17.

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.

J Clin Oncol. 2004 Jul 15;22(14):2816-25.

PMID:
15254049
18.

Sepsis in neutropenia--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Schiel X, Hebart H, Kern WV, Kiehl MG, Sölch JP, Wilhelm S, Ostermann H; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Ann Hematol. 2003 Oct;82 Suppl 2:S158-66. Epub 2003 Sep 9.

PMID:
13680167
19.

Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, Holler E, Beck R, Schwerdfeger R, Schumacher U, Hebart H, Martin H, Kienast J, Ullmann AJ, Maschmeyer G, Krüger W, Niederwieser D, Link H, Schmidt CA, Oettle H, Klingebiel T; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Ann Hematol. 2003 Oct;82 Suppl 2:S175-85. Epub 2003 Sep 10.

PMID:
13680165
20.

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.

Kiehl MG, Schäfer-Eckart K, Kröger M, Bornhäuser M, Basara N, Blau IW, Kienast J, Fauser AA, Ehninger G, Armstrong VW, Shipkova M.

Transplant Proc. 2002 Nov;34(7):2922-4. No abstract available.

PMID:
12431658
21.

Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience.

Basara N, Roemer E, Kraut L, Guenzelmann S, Schmetzer B, Kiehl MG, Fauser AA.

Bone Marrow Transplant. 2002 Nov;30(10):651-9.

22.

Eosinophilia indicates the evolution to acute graft-versus-host disease.

Basara N, Kiehl MG, Fauser AA.

Blood. 2002 Oct 15;100(8):3055. No abstract available.

23.

[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].

Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, Holler E, Beck R, Schwerdfeger R, Schumacher U, Hebart H, Martin H, Kienast J, Ullmann AJ, Maschmeyer G, Krüger W, Link H, Schmidt CA, Oettle H, Klingebiel T; Arbeitsgemeinschaft Infektionen der Deutschen Gesellschaft für Hämatologie und Onkologie.

Dtsch Med Wochenschr. 2001 Nov 9;126(45):1278-84. Review. German. No abstract available.

PMID:
11700570
24.

Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: report of an initial experience.

Grothaus-Pinke B, Günzelmann S, Fauser AA, Kiehl MG.

Transplantation. 2001 Oct 27;72(8):1456-8.

PMID:
11685121
25.

Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.

Kiehl MG, Basara N.

Blood. 2001 Sep 1;98(5):1626; author reply 1628. No abstract available.

26.

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.

Remberger M, Ringdén O, Blau IW, Ottinger H, Kremens B, Kiehl MG, Aschan J, Beelen DW, Basara N, Kumlien G, Fauser AA, Runde V.

Blood. 2001 Sep 15;98(6):1739-45.

27.

Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil.

Shipkova M, Armstrong VW, Kiehl MG, Niedmann PD, Schütz E, Oellerich M, Wieland E.

Clin Chem. 2001 Aug;47(8):1485-8. No abstract available.

28.

New immunosuppressants in BMT/GVHD.

Basara N, Günzelmann S, Willenbacher W, Fauser AA, Kiehl MG.

Transplant Proc. 2001 May;33(3):2220-2. Review. No abstract available.

PMID:
11377507
29.

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.

Basara N, Kiehl MG, Blau W, Römer E, Bischoff M, Schmetzer B, Kirsten D, Günzelmann S, Fauser AA.

Transplant Proc. 2001 May;33(3):2121-3. No abstract available.

PMID:
11377471
30.

New therapeutic modalities in the treatment of graft-versus-host disease.

Basara N, Kiehl MG, Fauser AA.

Crit Rev Oncol Hematol. 2001 May;38(2):129-38. Review.

PMID:
11311659
31.

Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT.

Hartert A, Willenbacher W, Günzelmann S, Roemer E, Basara N, Fauser AA, Kiehl MG.

Bone Marrow Transplant. 2001 Feb;27(3):337-40.

32.

Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab.

Willenbacher W, Basara N, Blau IW, Fauser AA, Kiehl MG.

Br J Haematol. 2001 Mar;112(3):820-3.

PMID:
11260089
33.

Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study.

Blau IW, Basara N, Lentini G, Guenzelmann S, Kirsten D, Schmetzer B, Bischoff M, Roemer E, Kiehl MG, Fauser AA.

Bone Marrow Transplant. 2001 Jan;27(1):27-33.

34.

Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.

Roemer E, Blau IW, Basara N, Kiehl MG, Bischoff M, Günzelmann S, Kirsten D, Sanchez H, Wocker EL, Fauser AA.

Clin Infect Dis. 2001 Jan;32(1):E1-8. Epub 2000 Dec 11.

PMID:
11118397
35.

A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study.

Fauser AA, Basara N, Blau IW, Kiehl MG.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S27-31.

PMID:
10933183
36.

New strategies in GVHD prophylaxis.

Kiehl MG, Shipkova M, Basara N, Blau WI, Fauser AA.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S16-9.

PMID:
10933180
37.

New strategies in the treatment of graft-versus-host disease.

Basara N, Blau IW, Willenbacher W, Kiehl MG, Fauser AA.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S12-5.

PMID:
10933179
38.

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite.

Kiehl MG, Shipkova M, Basara N, Blau IW, Schütz E, Armstrong VW, Oellerich M, Fauser AA.

Clin Biochem. 2000 Apr;33(3):203-8.

PMID:
10913519
39.

Mycophenolate mofetil in the prevention of rejection after kidney transplantation.

Kiehl MG.

Transplantation. 2000 Apr 27;69(8):1753-4. No abstract available.

PMID:
10836400
40.

Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.

Basara N, Blau WI, Kiehl MG, Schmetzer B, Bischoff M, Kirsten D, Günzelmann S, Fauser AA.

Clin Transplant. 2000 Apr;14(2):121-6.

PMID:
10770416
41.

Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.

Blau IW, Basara N, Bischoff M, Günzelmann S, Römer E, Kirsten D, Schmetzer B, Kiehl MG, Fauser AA.

Bone Marrow Transplant. 2000 Jan;25(1):41-5.

42.

Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants.

Basara N, Jelkmann W, Schmetzer B, Günzelmann S, Bischoff M, Blau WI, Kiehl MG, Fauser AA.

Thromb Haemost. 1999 Dec;82(6):1771-2. No abstract available.

PMID:
10613671
43.
44.

Chronic eosinophilic leukemia: successful treatment with an unrelated bone marrow transplantation.

Basara N, Markova J, Schmetzer B, Blau IW, Kiehl MG, Bischoff M, Kirsten D, Fauser AA.

Leuk Lymphoma. 1998 Dec;32(1-2):189-93.

PMID:
10037016
45.

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.

Basara N, Blau WI, Kiehl MG, Römer E, Rudolphi M, Bischoff M, Kirsten D, Sanchez H, Günzelmann S, Fauser AA.

Transplant Proc. 1998 Dec;30(8):4087-9. No abstract available.

PMID:
9865306
47.

Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome.

Kiehl MG, Ostermann H, Thomas M, Müller C, Cassens U, Kienast J.

Crit Care Med. 1998 Jul;26(7):1194-9.

PMID:
9671368
48.
49.

Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patients.

Kiehl MG, Ostermann H, Thomas M, Birkfellner T, Kienast J.

Chest. 1997 Nov 5;112(5):1214-20.

PMID:
9367460
50.

Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.

Kiehl MG, Ostermann H, Meyer J, Kienast J.

Intensive Care Med. 1997 May;23(5):561-6.

PMID:
9201529

Supplemental Content

Loading ...
Support Center